BMC Medical Co., Ltd. (SHE:301367)

Market Cap	5.74B -10.6%
Revenue (ttm)	1.20B +31.3%
Net Income	192.15M +8.3%
EPS	1.54 +8.7%
Shares Out	124.42M
PE Ratio	29.91
Forward PE	21.90
Dividend	0.47 (1.01%)
Ex-Dividend Date	May 28, 2026

Volume	1,055,611
Open	45.81
Previous Close	46.00
Day's Range	44.80 - 46.73
52-Week Range	45.51 - 74.59
Beta	0.53
Analysts	Strong Buy
Price Target	101.54 (+120.07%)
Earnings Date	Aug 20, 2026

About BMC Medical

BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well as PAP devices and CPAP masks. The company also provides snoring, sleep apnea, asthma, and chronic obstructive pulmonary disease solutions. BMC Medical...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2001
• Employees: 923
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301367

Financial Performance

In 2025, BMC Medical's revenue was 1.16 billion, an increase of 37.46% compared to the previous year's 843.48 million. Earnings were 225.66 million, an increase of 45.23%.